In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae
about
Acute coronary disease Athero-Inflammation: Therapeutic approachA Zebrafish Model for Chlamydia Infection with the Obligate Intracellular Pathogen Waddlia chondrophilaAn Unsettled Debate About the Potential Role of Infection in Pathogenesis of Atherosclerosis.Chlamydia pneumoniae infection in polarized epithelial cell linesChlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathwayDegradation of Chlamydia pneumoniae by peripheral blood monocytic cells.Chlamydia pneumoniae infection in human monocytesInvasion of human coronary artery cells by periodontal pathogensCell-mediated immune response during primary Chlamydia pneumoniae infectionChlamydia pneumoniae infects and multiplies in lymphocytes in vitro.Microorganisms in the aetiology of atherosclerosis.Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits.Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota.Comparing serum levels of cardiac biomarkers in cancer patients receiving chemotherapy and subjects with chronic periodontitisAmphiphysin IIm is required for survival of Chlamydia pneumoniae in macrophagesRetinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors.Chlamydiae as pathogens: new species and new issues.Identification of Sphingomyelinase on the Surface of Chlamydia pneumoniae: Possible Role in the Entry into Its Host Cells.Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor.Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infectionCharacterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells.Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cellsSimplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNAChlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s).Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes.Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cellsAtherosclerosis Induced by Chlamydophila pneumoniae: A Controversial TheoryEffects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells.Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis.
P2860
Q24793068-43F118AD-AE74-44F4-9921-5D68470ED41CQ30829026-29A6CC73-8D2A-4B55-A73A-BA4473F4803BQ33763278-BFE534C7-02D8-4FE0-BC8C-F822A66BDDCCQ33877198-0F8AB14B-0E51-47BD-A136-7CE1E7D5502DQ33883485-220FA31B-1688-4AE0-9A6C-4F309E19D914Q33946655-E52A0947-FDBB-40AE-B4BD-25323356A344Q34000720-16A94A4A-DD7C-4B7D-AC5B-AB91C9A8B47EQ34002403-AAFE5CA6-CE22-4265-86AB-300E6867C119Q34005391-D5C5A325-44CA-43B9-9DBB-8D64F82ED87DQ34009858-B411E74C-1BD7-438C-8E0A-3A81F082F30EQ34065709-FC381EB8-7457-42F7-A4B6-D94FEC49DF24Q35559048-8DBDA8F6-2C05-4AE0-979C-31599F8D2E94Q35583908-B0088686-417D-4A1E-92B3-34C5B1E37E6DQ35662826-BA493673-E8D0-4F98-9877-D05B7F7C14B6Q36243994-B640C369-FBEC-4F65-8FB6-54A50C516B5BQ36402455-9A167296-8D98-4F3B-A3E1-17D036101148Q36732330-3304B2C0-6CD4-4B7D-9B2C-235BF90BF2C3Q36838445-D4ADB34A-F680-4E0F-8A80-11A43D2ECFA3Q37844467-FB6D888B-B0FC-430E-84A1-CA3A44599734Q37868580-A210B3E5-3B5C-4DB6-8788-23DE154E9E53Q37871766-6BE58DE6-43F8-443B-AF2E-CE364E69BD38Q37873100-C7824DE0-6CDF-41D2-BCCA-29DBD2F5196FQ37873267-DF2121C5-19E4-4377-BF7B-ABD1E255CA23Q37875477-08270F6E-A108-4EA6-A2C3-D497BAD98109Q37876249-14C848B4-F8A9-4405-B49D-8C571B0EC04EQ37876764-D3196148-154D-412E-AC86-E85406AFBEE5Q37878378-AF535697-FDC4-4965-BC0D-8380649FC52BQ37879018-DD6F41EB-BFDF-4202-B665-5E12FC22A5ADQ37881299-A7C430AD-F90D-47C1-BEBC-CD5DD9EC096AQ39365197-23E328EA-6EB4-41BA-9F30-AA5F34776435Q40968088-7D31F12E-7E50-4B1F-9697-E066D4E374CBQ52330706-CD6D2F34-55CC-47C9-9D8C-4FF4D3BF6F4A
P2860
In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
In vitro susceptibility of hum ...... tion with Chlamydia pneumoniae
@ast
In vitro susceptibility of hum ...... tion with Chlamydia pneumoniae
@en
type
label
In vitro susceptibility of hum ...... tion with Chlamydia pneumoniae
@ast
In vitro susceptibility of hum ...... tion with Chlamydia pneumoniae
@en
prefLabel
In vitro susceptibility of hum ...... tion with Chlamydia pneumoniae
@ast
In vitro susceptibility of hum ...... tion with Chlamydia pneumoniae
@en
P2093
P2860
P1476
In vitro susceptibility of hum ...... tion with Chlamydia pneumoniae
@en
P2093
P2860
P304
P407
P577
1995-09-01T00:00:00Z